About this event

  • Date and time Fri 28 Feb 2020 from 8:15am to 5:30pm
  • Location Royal Society of Medicine
  • Organised by Urology

Update your knowledge on the endourological practice of urology - a large and important practice in Urology. This meeting will highlight the recent key issues and best practice in endourological practice from lithotripsy to metabolic aspects. 

Well-known experts in the field will share their experiences, updates, and management of stone diseases. All aspects of stone diseases will be discussed including lithotripsy, endourological procedures, PCNL, and metabolic assessment of stones and challenging cases. The programme is comprehensive and advocates the best practice that is to follow in stone management and surgical techniques.

There will be plenty of videos on surgical techniques and lots of time for discussion.

Topics include:

  • Updates on the latest management of stone patients
  • Techniques of surgery
  • Comprehensive care for stone patients including their metabolic workup and complex patients
  • The latest guidelines for the best practice
  • Complex cases and their management with world experts
  • The management of upper urinary tract cancers

We would like to thank our exhibitors:

Boston Scientific, Cambridge Healthcare, CJ Medical, Coloplast, Cook Medical, Karl Storz, Olympus Medical, Rocamed and Storz Medical

Please note that none of the companies listed have had any influence or involvement over the agenda, content or organisation of this meeting.

Key speakers

Marianne Brehmer

Dr Marianne Brehmer, MD, PhD

Specialist in advanced endourology.

Speaker's biography

Dr Brehmer is involved in several national and international scientific groups. She is the chairman of a research group on upper tract urothelial cancer at the Karolinska Institutet and she is the main supervisor for PhD-students. Since February 2017 she is responsible for the advanced endourology activity at Danderyd University Hospital, Stockholm, Sweden. Dr Brehmer was educated at the Karolinska Institutet, Stockholm, Sweden. She has been qualified urologist since 1994. She got her PhD degree in 1999 and did a post-doc in Edinburgh, UK, 2000-2001. Dr Brehmer got her endourology training in Stockholm, Örebro and Edinburgh. She was for 3 years responsible for the stone and endourology activity at Uppsala University Hospital. In 2003 she moved to the department of urology at the Karolinska University Hospital where she for 10 years was the chairperson of the Stone and Endourological Team. During three years, 2013-2016, Dr Brehmer was the Head of department at the department of urology, Aarhus University Hospital, Denmark where she was developing and performing advanced endourology in the department. Dr Brehmer has since many years been active in developing and improving the training of urologists. She was 2002-2013 the Swedish delegate for the European Board of Urology, EBU, where she was the president 2008‐2010. During her time in the EBU, she was in charge of developing a system for certification of subspeciality centres.

John D. Denstedt

John D. Denstedt, MD, FRCSC, FACS, FCAHS

Treasurer of the Endourological Society, Managing Editor of the Journal of Endourology and Member, Board of Directors of the American Urological Association. 

Speaker's biography

Dr John Denstedt graduated from medical school in 1982 at The University of Western Ontario in London, Canada. He completed his residency in Urology at Western between 1983 and 1987 followed by a fellowship in Endourology at Washington University in St. Louis. He returned to London and joined the Division of Urology in the Department of Surgery at Western in 1990.

In July 2002 he assumed the role of City-Wide Chair and Chief of the Department of Surgery at Western University and served in this role for 14 years. Dr Denstedt is a Past Chair of the Canadian Association of Surgical Chairs and a past member of the American Urological Association Board of Directors. He completed a 10 year term as Treasurer of the Endourological Society in 2018.

While maintaining an active clinical practice, Dr Denstedt is an internationally renowned scholar in urology with career accomplishments encompassing over 250 published papers and book chapters, more than 400 guest professorships in countries throughout the world and numerous honours and awards including being the first Canadian to have won the Gold Cystoscope Award from the American Urological Association in 1998. In 2019 he was awarded the Lifetime Achievement Award from the Endourological Society. Dr Denstedt has served on the Editorial Board of eight major journals in Urology and is the immediate past Executive Editor of the Journal of Endourology. He is currently the Secretary of the American Urological Association.

David S Goldfarb

Dr David S. Goldfarb, MD, FACP, FASN, FNKF

Professor of Medicine and Physiology at NYU School of Medicine, USA, Clinical Chief of Nephrology at NYU, Chief of Nephrology at the NY VAMC and co-director of the Kidney Stone Prevention Program at NYU Langone Health.

Speaker's biography

Dr Goldfarb graduated from Yale College and Yale School of Medicine and completed his residency training in internal medicine and nephrology training at NYU/New York VA. Dr Goldfarb is the former President of the New York Society of Nephrology and of the ROCK Society (Research on Calculus Kinetics). Currently he is a member of the medical advisory boards of the National Kidney Foundation of Greater New York and of the Oxalosis and Hyperoxaluria Foundation. He teaches renal physiology and pathophysiology at NYU and was voted “The Distinguished Teacher in the Basic Sciences” by three classes. He is a former associate editor of the Clinical Journal of the American Society of Nephrology (CJASN), and currently is an editorial board member of Kidney International, JASN, CJASN, and Urolithiasis. He serves as the principal investigator of the cystinuria component of the Rare Kidney Stone Consortium, and as a member of the board of directors of the International Cystinuria Foundation. He received the “Stone Crusher of the Year” award in 2014 from the Oxalosis and Hyperoxaluria Foundation and the “Nephrologist of the Year” award in 2016 from the American Kidney Fund. He has had three calcium oxalate stones.


View the programme

Registration, tea and coffee
Welcome and introduction

Mr Michael Dinneen, Consultant Urological Surgeon at Chelsea and Westminster Hospital, London and President of the Urology Section, Royal Society of Medicine

Miniaturisation of PCNL

Chairs: Mr Michael Dinneen and Professor Sri Sriprasad, Professor of Urology and Consultant Urologist, Darent Valley Hospital, Dartford and Gravesham NHS Trust and Canterbury Christ Church University

RIRS vs Mini PCNL for renal stones: Who will win the race

Dr John Denstedt, Professor of Urology, Western University London, Canada

Is suction a game changer for miniaturised PCNL?

Mr Simon Choong, Professor of Urology, Consultant Urological Surgeon, University College London Hospitals NHS Foundation Trust

How small can we go? Pushing the boundaries of mini-PCNL

Mr Hari Ratan, Consultant Urological Surgeon, Nottingham University Hospitals NHS Trust

Tea and coffee break

Genetics and metabolic aspects

Chairs: Mr Ben Turney, Senior Clinical Researcher in Urology, University of Oxford and Miss Kay Thomas, Consultant Urological Surgeon and Deputy Medical Director, Stone Unit, Guy's and St Thomas' NHS Foundation Trust

The exposome for kidney stones

Dr David Goldfarb, Clinical Chief, Nephrology Division, Ney York University Langone Health and Professor of Medicine and Physiology, Ney York Univeristy School of Medicine

Exploring the genetic basis of kidney stone disease

Dr Sarah Howles, National Institute for Health Research Academic Clinical Lecturer in Urology, University of Oxford

Metabolic management – a guide for urologists

Dr Shabbir Moochhala, Consultant Nephrologist, Royal Free Hospital

Thames water or Evian – what’s best for kidney stone prevention?

Miss Susan Willis, Consultant Urologist, Guy's and St Thomas' NHS Foundation Trust

Debate: Potassium Citrate for all!

For: Dr David Goldfarb, Against: Mr Matthew Bultitude, Consultant Urologist, Guy’s and St. Thomas’ NHS Foundation Trust 


Shockwave lithotripsy and ureteroscopy

Chairs: Dr Oliver Wiseman, Consultant Urologist, Cambridge University Hospitals NHS Trust and Mr Jake Patterson, Consultant Urological Surgeon, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust

ESWL - Back in fashion in 2020?

Mr Ben Turney

Let’s be honest … What stone-free rates are we really getting with flexible ureteroscopy?

Dr Marco Bolgeri, Consultant Urologist, St. George’s University Hospital NHS Foundation Trust London

Managing stones in children: What's different?

Mr Ben Grey, Consultant Urological Surgeon, Manchester University Hospitals NHS Foundation Trust


Upper tract urothelial carcinoma

Chairs: Mr Benjamin Challacombe, Consultant Urological Surgeon and Honorary Senior Lecturer, Guy’s and St Thomas Hospitals NHS Foundation Trust, King’s College London and Mr Mattew Bultitude 

Getting the most out of ureteroscopic biopsies

Miss Kay Thomas

Personalised management of UTUC

Dr Marianne Brehmer, Consultant Urologist, Division of Urology, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet

Nephro-ureterectomy: What to do with the lower end?

Mr Francis Keeley, Consultant Urologist, Bristol Urological Institute, North Bristol NHS Trust

The expanding role of chemo and immunotherapy in UTUC

Dr Deborah Enting, Consultant Medical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust


How I do it? Tips and tricks

Chairs: Mr Ranan Dasgupta, Consultant Urological Surgeon, Imperial College Healthcare NHS Trust and Mr Hari Ratan

How do I minimise exposure to radiation during URS and PCNL?

Miss Siân Allen, Consultant Urological Surgeon, University College London Hospital

ECIRS: How I do it? Tips and tricks

Mr Stephen Gordon, Consultant Urologist, Epsom and St.Helier University Hospitals NHS Trust

Stones in transplant kidney

Mr Subu Subramonian, Consultant Urological Surgeon, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust

Supine PCNL in horseshoe kidney

Mr Faqar Anjum, Consultant Urological Surgeon, Darent Valley Hospital, Dartford and Gravesham NHS Trust

Adjusting laser settings for optimal outcome

Mr Jake Patterson

Metabolic assessment of the tricky stone patient

Dr David Goldfarb 

Tea and coffee break

Challenging cases

Chairs: Mr Daron Smith, Endloluminal Endourologist, University College Hospital at Westmoreland Street, Mr Subu Subramonian and Professor Sri Sriprasad

Dr David Goldfarb, Dr John Denstedt, Dr Marianne Brehmer, Mr Jonathan Glass, Consultant Urologist, Guy's and St Thomas' NHS Foundation Trust and Dr Oliver Wiseman

Close of meeting



Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Other events of interest